Last reviewed · How we verify
NCT07332520: BIOPHF
Predicting Heart Failure Outcomes With Biomarkers and Imaging
trial in Heart Failure in 4,000 participants. Completed in 31 January 2025.
31 December 2024
Quick facts
| Lead sponsor | Xinjiang Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 4,000 |
| Start date | 1 January 2012 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 January 2025 |
Conditions studied
- Heart Failure — all drugs for Heart Failure →
- Heart Failure, Systolic — all drugs for Heart Failure, Systolic →
- Heart Failure, Diastolic — all drugs for Heart Failure, Diastolic →
- Heart Failure With Reduced Ejection Fraction (HFrEF) — all drugs for Heart Failure With Reduced Ejection Fraction (HFrEF) →
Sponsor
Xinjiang Medical University
Who can join
18 and older, any sex, with Heart Failure or Heart Failure, Systolic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to develop a better model to predict one-year risk of death in patients with heart failure. We will test whether combining information from routine blood tests (like NT-proBNP) and heart scans (measuring features like epicardial fat density) improves risk prediction compared to using either type of data alone. This is a retrospective study using existing medical records of patients treated for chronic heart failure at Xinjiang Medical University First Affiliated Hospital between 2012 and 2024. No new patient contact or interventions are involved. The goal is to enable more accurate, personalized risk assessment across different types of heart failure (HFrEF, HFmrEF, HFpEF).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07332520
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Heart Failure
Currently open trials in the same condition.
- NCT06118983 — Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF) · NA · recruiting
- NCT07496372 — Efficacy and Safety of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Injection (HiCM-188) in Advanced Heart · Phase 3 · recruiting
- NCT07527156 — Prolonged Nasogastric Administration of Ketones in Decompensated Heart Failure · Phase 4 · recruiting
- NCT07263035 — Urine Sodium-Driven Diuretic Adjustment Strategy in Acute Decompensated Heart Failure · Phase 4 · recruiting
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
Other Xinjiang Medical University trials
Trials by the same sponsor.
- NCT07534410 — The Prognostic Value of Cardiopulmonary Exercise Testing Parameters in Patients With Coronary Heart Disease: A Retrospec · not yet recruiting
- NCT07355088 — Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Pr · not yet recruiting
- NCT06513585 — Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy · NA · recruiting
- NCT06459934 — Clinical Outcomes of Cardiovascular Disease · recruiting
- NCT06513676 — Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07332520 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Xinjiang Medical University
- Last refreshed: 27 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07332520.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing